Therapeutic Apheresis & Extracorporeal Procedures
Extracorporeal Photopheresis (ECP)
An established extracorporeal cellular therapy used in selected immune-mediated and hematological conditions.
Overview
Extracorporeal Photopheresis (ECP), is an established extracorporeal cellular therapy used in selected immune-mediated and hematological conditions.
During ECP, a fraction of the patient's circulating white blood cells is collected by leukapheresis. The isolated leukocyte fraction is treated extracorporeally with the photosensitizing agent 8-methoxypsoralen (8-MOP) and subsequently exposed to ultraviolet-A (UVA) light under controlled conditions. The treated cells are then reinfused into the patient.
A Cellular Immunomodulatory Approach
The biological mechanisms of ECP are complex and remain the subject of ongoing research.
Current evidence indicates that 8-MOP/UVA exposure induces programmed cell death in a proportion of treated lymphocytes. Following reinfusion, interactions between these cells and the patient's immune system appear to influence antigen-presenting cells, dendritic-cell function, cytokine signaling and regulatory T-cell responses.
These mechanisms may contribute to the immunomodulatory effects observed clinically.
Importantly, ECP does not simply function as a conventional systemic immunosuppressive treatment. Rather, it represents a distinct extracorporeal cellular approach capable of modifying specific immune processes.
How ECP Works
- 01Leukocyte Collection
- 02Photosensitization
- 03UVA Photoactivation
- 04Autologous Reinfusion
Personalized Treatment Planning
ECP treatment schedules differ according to the underlying disease, disease activity, previous therapies, clinical response and applicable medical guidelines.
Before treatment, patients require an individual medical evaluation including assessment of the indication, vascular access, hematological parameters, concomitant medication and relevant contraindications.
Treatment response should be assessed systematically using established disease-specific clinical criteria.
At ICICM, extracorporeal procedures are integrated into an individualized medical strategy based on the patient's diagnosis, medical history, laboratory findings and therapeutic objectives.
The indication for ECP is determined medically and individually. Not every immune-mediated condition represents an established indication for extracorporeal photopheresis, and evidence differs considerably between diseases.
Gallery
Further procedures
Medical assessment before procedure
The availability of a procedure does not mean that it is appropriate for every patient. Before any procedure is considered, the patient's medical history, current clinical situation, available diagnostic information and relevant medical factors are evaluated.
No diagnostic or therapeutic procedure can guarantee a specific clinical outcome.